Abstract
Sevoflurane has been reported to have anti-tumorigenic effects in glioma. Circ_0000215 was found to play vital functions in the pathological progressions of glioma. However, whether circ_0000215 mediates the inhibitory effects of sevoflurane on glioma cells remains unclear. In vitro assays were performed using cell counting kit-8, flow cytometry, transwell and Western blot assays. The expression levels of circ_0000215, microRNA (miR)-1200 and NCR3LG1 (Natural Killer Cell Cytotoxicity Receptor 3 Ligand 1) were detected using quantitative real-time polymerase chain reaction (qRT-PCR) and/or Western blot. The dual-luciferase reporter assay and pull-down assay were used to investigate the relationship between miR-1200 and circ_0000215 or NCR3LG1. In vivo assay was conducted using xenograft nude mice model. In vitro assays suggested that sevoflurane repressed glioma cell proliferation, metastasis and induced apoptosis as well as hindered tumor growth in vivo, which were reversed by circ_0000215 overexpression. Mechanically, circ_0000215 was confirmed to directly target miR-1200, and NCR3LG1 was a target of miR-1200 in glioma cells. Importantly, circ_0000215 could regulate NCR3LG1 expression via miR-1200. Besides that, rescue assay suggested that circ_0000215 attenuated the inhibitory effects of sevoflurane on glioma cell growth and metastasis, which were reversed by miR-1200 overexpression or NCR3LG1 knockdown. Our study revealed that sevoflurane could suppress glioma tumorigenesis by regulating circ_0000215/miR-1200/NCR3LG1 axis, suggesting a new insight into the therapeutic potential of sevoflurane in glioma treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
All data generated or analysed during this study are included in this published article.
References
Alifieris C, Trafalis DT (2015) Glioblastoma multiforme: Pathogenesis and treatment. Pharmacol Ther 152:63–82. https://doi.org/10.1016/j.pharmthera.2015.05.005
Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, Haldeman B, Ostrander CD, Kaifu T, Chabannon C, Moretta A, West R, Xu W, Vivier E, Levin SD (2009) The B7 family member B7–H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 206:1495–1503. https://doi.org/10.1084/jem.20090681
Chen Y, Mo J, Jia X, He Y (2018) The B7 Family Member B7–H6: a New Bane of Tumor. Pathol Oncol Res 24:717–721. https://doi.org/10.1007/s12253-017-0357-5
De Santa F, Iosue I, Del Rio A, Fazi F (2013) microRNA biogenesis pathway as a therapeutic target for human disease and cancer. Curr Pharm Des 19:745–764
Fiegler N, Textor S, Arnold A, Rölle A, Oehme I, Breuhahn K, Moldenhauer G, Witzens-Harig M, Cerwenka A (2013) Downregulation of the activating NKp30 ligand B7–H6 by HDAC inhibitors impairs tumor cell recognition by NK cells. Blood 122:684–693. https://doi.org/10.1182/blood-2013-02-482513
Gao C, He XF, Xu QR, Xu YJ, Shen J (2019a) Sevoflurane downregulates insulin-like growth factor-1 to inhibit cell proliferation, invasion and trigger apoptosis in glioma through the PI3K/AKT signaling pathway. Anticancer Drugs 30:e0744. https://doi.org/10.1097/cad.0000000000000744
Gao K, Su Z, Liu H, Liu Y (2019b) Anti-proliferation and anti-metastatic effects of sevoflurane on human osteosarcoma U2OS and Saos-2 cells. Exp Mol Pathol 108:121–130. https://doi.org/10.1016/j.yexmp.2019.04.005
Geng Y, Jiang J, Wu C (2018) Function and clinical significance of circRNAs in solid tumors. J Hematol Oncol 11:98. https://doi.org/10.1186/s13045-018-0643-z
Goodenberger ML, Jenkins RB (2012) Genetics of adult glioma. Cancer Genet 205:613–621. https://doi.org/10.1016/j.cancergen.2012.10.009
Guil S, Esteller M (2015) RNA-RNA interactions in gene regulation: the coding and noncoding players. Trends Biochem Sci 40:248–256. https://doi.org/10.1016/j.tibs.2015.03.001
Han B, Chao J, Yao H (2018) Circular RNA and its mechanisms in disease: From the bench to the clinic. Pharmacol Ther 187:31–44. https://doi.org/10.1016/j.pharmthera.2018.01.010
He J, Zhao H, Liu X, Wang D, Wang Y, Ai Y, Yang J (2020) Sevoflurane suppresses cell viability and invasion and promotes cell apoptosis in colon cancer by modulating exosome-mediated circ-HMGCS1 via the miR-34a-5p/SGPP1 axis. Oncol Rep 44:2429–2442. https://doi.org/10.3892/or.2020.7783
Huang XY, Huang ZL, Xu YH, Zheng Q, Chen Z, Song W, Zhou J, Tang ZY, Huang XY (2017) Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma. Sci Rep 7:5428. https://doi.org/10.1038/s41598-017-05432-8
Jiang T, Wu W, Zhang H, Zhang X, Zhang D, Wang Q, Huang L, Wang Y, Hang C (2017) High expression of B7–H6 in human glioma tissues promotes tumor progression. Oncotarget 8:37435–37447. https://doi.org/10.18632/oncotarget.16391
Kang K, Wang Y (2019) Sevoflurane Inhibits Proliferation and Invasion of Human Ovarian Cancer Cells by Regulating JNK and p38 MAPK Signaling Pathway. Drug Des Devel Ther 13:4451–4460. https://doi.org/10.2147/dddt.s223581
Kvolik S, Dobrosevic B, Marczi S, Prlic L, Glavas-Obrovac L (2009) Different apoptosis ratios and gene expressions in two human cell lines after sevoflurane anaesthesia. Acta Anaesthesiol Scand 53:1192–1199. https://doi.org/10.1111/j.1399-6576.2009.02036.x
Lai RC, Shan WR, Zhou D, Zeng XQ, Zuo K, Pan DF, Zeng WA, Zuo ZY (2019) Sevoflurane promotes migration, invasion, and colony-forming ability of human glioblastoma cells possibly via increasing the expression of cell surface protein 44. Acta Pharmacol Sin 40:1424–1435. https://doi.org/10.1038/s41401-019-0221-0
Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178–196. https://doi.org/10.1038/nrm3758
Li H, Xia T, Guan Y, Yu Y (2020) Sevoflurane Regulates Glioma Progression by Circ_0002755/miR-628-5p/MAGT1 Axis. Cancer Manag Res 12:5085–5098. https://doi.org/10.2147/cmar.s242135
Liu S, Fang F, Song R, Gao X, Jiang M, Cang J (2018) Sevoflurane affects neurogenesis through cell cycle arrest via inhibiting wnt/β-catenin signaling pathway in mouse neural stem cells. Life Sci 209:34–42. https://doi.org/10.1016/j.lfs.2018.07.054
Liu L, Shi Y, Shi J, Wang H, Sheng Y, Jiang Q, Chen H, Li X, Dong J (2019) The long non-coding RNA SNHG1 promotes glioma progression by competitively binding to miR-194 to regulate PHLDA1 expression. Cell Death Dis 10:463. https://doi.org/10.1038/s41419-019-1698-7
Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK, Chong PP, Looi CY (2019) The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges. Cells 8. https://doi.org/10.3390/cells8101118
Müller-Edenborn B, Roth-Zʼgraggen B, Bartnicka K, Borgeat A, Hoos A, Borsig L, Beck-Schimmer B (2012) Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9. Anesthesiology 117:293–301. https://doi.org/10.1097/ALN.0b013e3182605df1
Mutalifu N, Du P, Zhang J, Akbar H, Yan B, Alimu S, Tong L, Luan X (2020) Circ_0000215 Increases the Expression of CXCR2 and Promoted the Progression of Glioma Cells by Sponging miR-495-3p. Technol Cancer Res Treat 19:1533033820957026. https://doi.org/10.1177/1533033820957026
Niwa H, Rowbotham DJ, Lambert DG, Buggy DJ (2013) Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery? J Anesth 27:731–741. https://doi.org/10.1007/s00540-013-1615-7
Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol 16:896–913. https://doi.org/10.1093/neuonc/nou087
Prelaj A, Rebuzzi SE, Grassi M, Salvati M, D’Elia A, Buttarelli F, Ferrara C, Tomao S, Bianco V (2019) Non-conventional fotemustine schedule as second-line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature. Mol Clin Oncol 10:58–66. https://doi.org/10.3892/mco.2018.1746
Shi F, Shi Z, Zhao Y, Tian J (2019) CircRNA hsa-circ-0014359 promotes glioma progression by regulating miR-153/PI3K signaling. Biochem Biophys Res Commun 510:614–620. https://doi.org/10.1016/j.bbrc.2019.02.019
Wang K, Sun Y, Tao W, Fei X, Chang C (2017) Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Lett 394:1–12. https://doi.org/10.1016/j.canlet.2016.12.036
Xu W, Xue R, Xia R, Liu WW, Zheng JW, Tang L, Kang LY, Wang W, Wei WT (2020) Sevoflurane impedes the progression of glioma through modulating the circular RNA has_circ_0012129/miR-761/TGIF2 axis. Eur Rev Med Pharmacol Sci 24:5534–5548. https://doi.org/10.26355/eurrev_202005_21339
Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J (2019a) The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer 18:4. https://doi.org/10.1186/s12943-018-0933-7
Yang X, Zheng YT, Rong W (2019b) Sevoflurane induces apoptosis and inhibits the growth and motility of colon cancer In vitro and in vivo via inactivating Ras/Raf/MEK/ERK signaling. Life Sci 239:116916. https://doi.org/10.1016/j.lfs.2019.116916
Zhang L, Wang J, Fu Z, Ai Y, Li Y, Wang Y, Wang Y (2019) Sevoflurane suppresses migration and invasion of glioma cells by regulating miR-146b-5p and MMP16. Artif Cells Nanomed Biotechnol 47:3306–3314. https://doi.org/10.1080/21691401.2019.1648282
Zhao H, Xing F, Yuan J, Li Z, Zhang W (2020) Sevoflurane inhibits migration and invasion of glioma cells via regulating miR-34a-5p/MMP-2 axis. Life Sci 256:117897. https://doi.org/10.1016/j.lfs.2020.117897
Funding
There is no funding.
Author information
Authors and Affiliations
Contributions
Zhitao Zhao conceived and designed the experiments, performed the experiments and analyzed and interpreted the data, wrote the paper. Baofeng Gao analyzed interpreted the data, performed the experiments. Xiaoling Zong and Ruiming Gao performed the experiments and analyzed the data. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
The research related to animals’ use has been complied with all the relevant national regulations and institutional policies for the care and use of animals. The animal studies were allowed by the Ethics Committee of Animal Research of Shandong Provincial Third Hospital.
Disclosure of interest
The authors declare that they have no financial conflicts of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhao, Z., Gao, B., Zong, X. et al. Sevoflurane impedes glioma progression via regulating circ_0000215/miR-1200/NCR3LG1 axis. Metab Brain Dis 36, 2003–2014 (2021). https://doi.org/10.1007/s11011-021-00817-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-021-00817-1